Home > Annual Financials > AARTI PHARMALABS

AARTI PHARMALABS Financial Statement Analysis
[BOM: 543748|NSE : AARTIPHARM]

The Revenues of AARTI PHARMALABS have increased by 62.11% YoY .
The Earnings Per Share (EPS) of AARTI PHARMALABS has increased by 12.08 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

AARTI PHARMALABS Last 5 Annual Financial Results
[BOM: 543748|NSE : AARTIPHARM]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Revenues ₹1,945 Cr₹1,200 Cr₹0.00 Cr₹0.00 Cr
Expenses ₹1,603 Cr₹995 Cr₹0.01 Cr₹0.01 Cr
Operating Profit (Excl OI) ₹342 Cr₹205 Cr₹-0.01 Cr₹-0.01 Cr
Other Income ₹2.32 Cr₹4.19 Cr₹0.00 Cr₹0.00 Cr
Interest ₹21 Cr₹12 Cr₹0.00 Cr₹0.00 Cr
Depreciation ₹63 Cr₹42 Cr₹0.00 Cr₹0.00 Cr
Profit Before Tax ₹261 Cr₹155 Cr₹-0.01 Cr₹-0.01 Cr
Profit After Tax ₹193 Cr₹122 Cr₹-0.01 Cr₹-0.01 Cr
Consolidated Net Profit ₹193 Cr₹122 Cr₹-0.01 Cr₹-0.01 Cr
Earnings Per Share (Rs)₹23.93₹21.35₹4,890.04₹-0.18
PAT Margin (%)11.719.9510.190.00
ROE(%)13.0813.3518.23-2.02
ROCE(%)16.7516.1119.40-1.87
Total Debt/Equity(x)0.150.140.250.08

Key Financials

Market Cap : ₹ 8,580.3 Cr
Revenue (TTM) : ₹ 2,115.1 Cr
Net Profit(TTM) : ₹ 272.4 Cr
EPS (TTM) : ₹ 30.1
P/E (TTM) : 31.5

Industry Peers & Returns1W1M1Y
AARTI PHARMALABS -1% 5.3% 52.6%
SUN PHARMACEUTICAL INDUSTRIES 1.7% 2% -0.6%
DIVIS LABORATORIES 0.4% -2% 37.3%
CIPLA 6.8% 4.6% -0.5%
TORRENT PHARMACEUTICALS 6% 10.5% 13.6%
DR REDDYS LABORATORIES 4.2% 1.3% -6.7%
MANKIND PHARMA -1.9% 9.9% 23.7%
ZYDUS LIFESCIENCES 3.4% 0.5% -18.8%
LUPIN 3.3% 2.4% 6.6%


AARTI PHARMALABS Revenues
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

62.11 %

5 Yr CAGR

0 %

Years Revenues % Change
Mar2024 ₹1,945 Cr
62.11
Mar2023 ₹1,200 Cr
0
Mar2022 ₹0.00 Cr
0
Mar2021 ₹0.00 Cr -


AARTI PHARMALABS Operating Profit
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

66.64 %

5 Yr CAGR

Positive

Years Operating Profit % Change
Mar2024 ₹342 Cr
66.64
Mar2023 ₹205 Cr
Positive
Mar2022 ₹-0.01 Cr
Negative
Mar2021 ₹-0.01 Cr -

Operating Margins
Y-o-Y

2.75 %

5 Yr CAGR

0

Years Operating Margin% % Change
Mar2024 17.58%
2.75
Mar2023 17.11%
0
Mar2022 0%
0
Mar2021 0% -

AARTI PHARMALABS Profit After Tax
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

58.28 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2024 ₹193 Cr
58.28
Mar2023 ₹122 Cr
Positive
Mar2022 ₹-0.01 Cr
Negative
Mar2021 ₹-0.01 Cr -

PAT Margins
Y-o-Y

17.69 %

5 Yr CAGR

0

Years PAT Margin(%) % Change
Mar2024 11.71 %
17.69
Mar2023 9.95 %
-2.36
Mar2022 10.19 %
0
Mar2021 0 % -

AARTI PHARMALABS Earnings Per Share (EPS)
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

12.08 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2024 ₹24
12.08
Mar2023 ₹21
-99.56
Mar2022 ₹4,890
Positive
Mar2021 ₹-0.18 -

AARTI PHARMALABS Return on Capital Employed (ROCE)
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

3.97 %

5 Yr CAGR

Positive

Years ROCE % Change
Mar2024 16.75%
3.97
Mar2023 16.11%
-16.96
Mar2022 19.4%
Positive
Mar2021 -1.87% -

AARTI PHARMALABS Share Price vs Sensex

Current Share Price : ₹947.1
Current MarketCap: ₹ 8,580.3 Cr
Updated EOD on :Jul 30,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-1%

5.3%

52.6%

SENSEX

-1.5%

-2.5%

0.2%

AARTI PHARMALABS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE 1.9% 3.6% 14.2%
BSE SMALLCAP -2.4% -1.5% -0.8%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 -1.6% -0.4% -1.4%
NIFTY TOTAL MARKET -1.7% -2.4% -1.1%

You may also like the below Video Courses


FAQ about AARTI PHARMALABS Financials


How the annual revenues of AARTI PHARMALABS have changed ?

The Revenues of AARTI PHARMALABS have increased by 62.11% YoY .

How the Earnings per Share (EPS) of AARTI PHARMALABS have changed?

The Earnings Per Share (EPS) of AARTI PHARMALABS has increased by 12.08 % YoY .